UROY vs NXE Stock Comparison

Uranium Royalty and NexGen Energy Prices as of Oct 26, 2026 Peers: Industry group
NXE NexGen Energy Ltd.
$8.32 -9.5% 1M -4.8% 1Y
Market cap
$5.17B
P/E
–
Revenue (TTM)
—
Div. yield
–
Uranium Energy
4 wins

Head to Head

4 decided of 12

NexGen Energy leads on 4 of the 12 questions below (NexGen Energy 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionUROYNXELeader
Larger companyMarket capitalisation $583.21M $5.17B NXE
Cheaper on earningsLower P/E, profitable companies only 32.9x -28.0x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 34.0x — –
Faster revenue growthRevenue growth, trailing twelve months — — –
More profitableNet margin, trailing twelve months — — –
Better return on capitalReturn on invested capital — — –
Less leveragedLower net debt / EBITDA — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -15.6% -4.8% NXE
Better 5-year returnAnnualised price return, 5 years -8.0%/yr +7.8%/yr NXE
Less volatileAnnualised volatility, 1 year 69.6% 55.7% NXE
Higher overall scoreMean of the five percentile scores vs peers — 48/100 –

Percentile Scorecard

UROYNXE

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisUROYNXE
Valuation 86 #4 of 23 59 #10 of 23
Growth – 20 #17 of 21
Profitability – 35 #12 of 18
Financial Health 10 #20 of 22 57 #10 of 22
Shareholder Returns – 67 #4 of 10
Overall – 48
  • UROY ranked among 25 companies in Coal and Uranium
  • NXE ranked among 25 companies in Coal and Uranium

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodUROYNXESPY
1 month -17.9%-9.5% -0.8%
3 months +24.1%-10.6% +3.5%
6 months -10.3%-33.3% +7.0%
Year to date -4.0%-9.6% +12.2%
1 year -15.6%-4.8% +13.0%
3 years +28.8%+44.7% +86.3%
3 years, per year +8.8%+13.1% +23.1%
5 years -34.2%+45.7% +68.6%
5 years, per year -8.0%+7.8% +11.0%
10 years —+617.2% +258.0%
10 years, per year —+21.8% +13.6%

Risk

MeasureUROYNXESPY
Volatility, 1Y 69.6%55.7% 12.7%
Downside volatility, 1Y 68.0%57.9% 12.7%
Beta vs S&P 500, 1Y 2.342.35 1.00
Return / volatility, 1Y -0.22-0.09 1.02
Max drawdown, 5Y -74.2%-54.3% -25.4%
From 52-week high -37.7%-40.2% -1.8%
52-week high $5.46$13.92 $779.14
52-week low $2.61$7.56 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleUROYNXE
P/E now vs peer median 32.9xmedian 26.7x -26.5xmedian 26.7x
P/S now vs peer median 10.3xmedian 6.7x —median 6.7x
EV/EBITDA now vs peer median —median 28.0x -26.2xmedian 28.0x
P/FCF now vs peer median 10.1xmedian 10.1x -38.9xmedian 10.1x
P/B now vs peer median 0.5xmedian 1.2x 4.2xmedian 1.2x
PEG now vs peer median —median 45.36 0.65median 45.36

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsUROYNXE
Net income – -$184.50M
Free cash flow – -$141.17M
EPS (diluted) – $-0.31
Cash & equivalents $103.65M $532.18M
Total debt $592.76M –
Shares (diluted) 157.28M 588.40M
Enterprise value $152.98M $2.71B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricUROYNXE
P/E 32.9x -26.5x
P/FCF 10.1x -38.9x
P/Operating cash flow – -75.5x
P/S 10.3x –
P/B 0.5x 4.2x
P/Tangible book 0.5x 4.2x
EV/EBITDA – -26.2x
EV/EBIT – -26.0x
EV/Revenue – –
EV/FCF – -34.1x
EV/Operating cash flow – -66.1x
PEG (3Y EPS CAGR) – 0.65

Growth

14 metrics
MetricUROYNXE
Revenue growth (1Y) – –
Revenue CAGR (3Y) – –
Gross profit growth (1Y) – –
Gross profit CAGR (3Y) – –
Operating income growth (1Y) – –
Operating income CAGR (3Y) – –
Net income growth (1Y) – -122.1%
Net income CAGR (3Y) – -63.7%
EPS growth (1Y) – -279.2%
EPS CAGR (3Y) – -40.6%
Operating cash flow growth (1Y) – -330.0%
Operating cash flow CAGR (3Y) – -43.4%
Free cash flow growth (1Y) – -91.6%
Free cash flow CAGR (3Y) – -25.3%

Profitability

14 metrics
MetricUROYNXE
Gross margin – –
EBITDA margin – –
Operating margin – –
Pretax margin – –
Net margin – –
FCF margin – –
Operating cash flow margin – –
Return on equity – -16.3%
Return on assets – -11.6%
Return on invested capital – –
Return on capital employed – -14.2%
Asset turnover – –
Cash conversion (OCF / net income) – 0.4x
Stock comp / revenue – –

Financial Health

11 metrics
MetricUROYNXE
Debt / assets 31.0% –
Debt / equity 0.5x –
Net debt / EBITDA – –
Debt / FCF – –
Liabilities / assets 42.9% 27.1%
Equity / assets 57.1% 72.9%
Interest coverage – –
Current ratio 0.9x 1.5x
Quick ratio 0.9x 1.4x
Cash ratio 0.8x 1.4x
Altman Z-score – –

Shareholder Returns

7 metrics
MetricUROYNXE
Dividend yield – –
Net buyback yield – -1.2%
Shareholder yield – -1.2%
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusUROYNXE
Forward P/E 34.0xFY2026 –
EPS, next fiscal year $0.10FY2026 $-0.14FY2026
EPS growth, next FY -65.5%FY2026 –
EPS growth, the year after -120.0% –
Revenue, next fiscal year $89.43MFY2026 $0.00FY2026
Revenue growth, next FY -52.2%FY2026 –
Revenue growth, the year after -50.8% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersUROYNXE
Held by institutions 9.3% 56.4%
Institutions holding 109 274
Change in shares held, QoQ -14.3% +1.7%
Institutions buying 50 136
Institutions selling 37 78
Buyers to sellers 1.35 1.74

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

UROYNXE
UROY 1.00 0.75
NXE 0.75 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, UROY and NXE?

NexGen Energy (NXE) is the largest by market capitalisation: Uranium Royalty (UROY) $583.21M, NexGen Energy (NXE) $5.17B.

Which stock has performed better?

Over the past year NexGen Energy (NXE) returned the most: Uranium Royalty (UROY) -15.6%, NexGen Energy (NXE) -4.8%. Over five years, NexGen Energy (NXE) compounded fastest (Uranium Royalty (UROY) -8.0%/yr, NexGen Energy (NXE) +7.8%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, NexGen Energy (NXE) has been the steadiest (Uranium Royalty (UROY) 69.6%, NexGen Energy (NXE) 55.7%). Volatility measures how widely the price swings, not the risk of the business.

Do UROY and NXE move together?

Their daily returns over the past year have a correlation of 0.75, a strong positive relationship. Holding both adds little diversification.

Which is the better stock, UROY and NXE?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, NexGen Energy (NXE) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.